The medical device and therapy related information on this website is aimed exclusively at healthcare professionals located within the European Union.
Not all products are cleared or available for sale in all EU countries. Please check the relevant country web site for details.
By clicking on the button “Accepted and Confirmed” you assure that you have taken note of this information and that you are a healthcare professional located within the European Union.
| Designed for simplicity and convenience during operation, the stay•safe system facilitates better patient compliance. | |
|---|---|
| Extra safety built in | The unique PIN system automatically closes the catheter extension before disconnection. This minimises the possibility of related touch contamination. |
| 50% less risk steps with stay•safe | PIN technology eliminates 1,460 risk steps* per patient year compared with conventional systems, thus contributing lower risk of contamination. |
| Guided operation | The control switch of the DISC guides patients through all essential steps of the procedure facilitating confidence and improved compliance. |
| Free from breaking cones and clamps | With the DISC your patients do not have to worry about clamping the wrong lines or forgetting where they are in the procedure. |
| System | stay•safe | Other systems |
|---|---|---|
| Connections per day | 4 | 4 |
| Disconnections per day | 0 | 4 |
| Risk steps per year | 1,460 | 2,920 |
1 Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL Kim YS, Ahn C, Kim MJ, and Shin SK. Superior patient survival for continous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation concentration (balance). Peritoneal Dialysis International 2005; 25(3):248-255.
2 Lee YL, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, and Shin SK. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrology Dialysis Transplantation 2006;21:2893-2899.
3 Dunst R, Alscher DM, Knödler P, Pfinder-Nohe E, Tast C, Kuhlmann U, and Mettang T. Peritonitis rates using different CAPD systems. Peritoneal Dialysis International 2001;21(Suppl.2):S65
4 Van Biesen W, Kirchgessner J, Schilling H, Lage C, Lambert MC, Passilick-Deetjen J. stay•safe®, a new PVC-free system for PD: Results of the multicenter trial. Peritoneal Dialysis International 1999;19(Suppl.1):S43.
5 Lambert MC, Lage C, Kirchgessner J. stay•safe, a new PVC-free system in long-term CAPD treatment. European Dialysis and Transplant Nurses Association/European Renal Care Association Journal 1999;25(3):30-34.
6 Issad B, Taamma R, Allouache M, Deray G. stay•safe, a new PVC-free system for CAPD: Results of a multicenter survey. Peritoneal Dialysis International 2001;21(Suppl.1):S34.
7 Basile C, De Padova F, Giordano R, Montanaro A, De Maio P, Di Marco L, Ligorio VA, Semeraro A. The incidence of peritonitis declines after implementation of the stay•safe® system (sss). Blood Purification 2001;19:79.
